| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Orchestra BioMed Holdings, Inc. | 2,432,089 | 6.8% | EDGAR |
| SC 13G/A | 2024-02-14 | Medtronic plc | Orchestra BioMed Holdings, Inc. | 5,868,916 | 16.4% | EDGAR |
| SC 13G | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Orchestra BioMed Holdings, Inc. | 622,608 | 1.7% | EDGAR |
| SC 13G | 2023-09-22 | Orchestra BioMed Holdings, Inc. | Motus GI Holdings, Inc. | 804,096 | 10.1% | EDGAR |
| SC 13G | 2023-09-13 | PERCEPTIVE ADVISORS LLC | Orchestra BioMed Holdings, Inc. | 2,432,089 | 6.8% | EDGAR |
| SC 13D/A | 2023-05-05 | RTW INVESTMENTS, LP | Orchestra BioMed Holdings, Inc. | 5,620,645 | 15.7% | EDGAR |
| SC 13G | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Orchestra BioMed Holdings, Inc. | 685,801 | 6.1% | EDGAR |
| SC 13G | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | Orchestra BioMed Holdings, Inc. | 610,283 | 5.4% | EDGAR |
| SC 13D | 2023-02-07 | Smith Geoffrey Wade | Orchestra BioMed Holdings, Inc. | 1,713,297 | 5.4% | EDGAR |
| SC 13G | 2023-02-06 | Medtronic plc | Orchestra BioMed Holdings, Inc. | 4,999,423 | 15.8% | EDGAR |
| SC 13D/A | 2023-01-30 | HSAC 2 Holdings, LLC | Orchestra BioMed Holdings, Inc. | 5,110,956 | 16.2% | EDGAR |
| SC 13D/A | 2023-01-27 | RTW INVESTMENTS, LP | Orchestra BioMed Holdings, Inc. | 5,118,512 | 16.2% | EDGAR |
| SC 13D | 2022-10-12 | HSAC 2 Holdings, LLC | Health Sciences Acquisitions Corp 2 | 4,360,956 | 38.9% | EDGAR |
| SC 13D | 2022-10-12 | RTW INVESTMENTS, LP | Health Sciences Acquisitions Corp 2 | 1,000,000 | 8.9% | EDGAR |
| SC 13G | 2021-02-16 | HSAC 2 Holdings, LLC | Health Sciences Acquisitions Corp 2 | 10 | 21.3% | EDGAR |